How the bio revolution could transform the competitive landscape
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Valor |
|---|---|---|---|
| LDR | 00000cam a22000004b 4500 | ||
| 001 | MAP20200016199 | ||
| 003 | MAP | ||
| 005 | 20230321114200.0 | ||
| 008 | 180511e20200501usa|||| ||| ||eng d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a922.113 | ||
| 110 | 2 | $0MAPA20200011316$aChui, Michael | |
| 245 | 1 | 0 | $aHow the bio revolution could transform the competitive landscape$cMichael Chui, Matthias Evers, Alice Zheng |
| 260 | $aNew York$bMcKinsey & Company$c2020 | ||
| 300 | $a10 p. | ||
| 520 | $aFueled by breakthroughs in biological science and the confluence of exponential advances in data, analytics, and digitization, what until recently might have read like a page out of a science fiction novel is becoming a reality. Moreover, biological innovations have been deployed to aid in the response to COVID-19, allowing for faster identification of the virus, more effective diagnostics, and new bioengineered treatments.1 The wide-ranging implications for business executives should go well beyond the obvious and expected. | ||
| 650 | 4 | $0MAPA20200005599$aCOVID-19 | |
| 650 | 4 | $0MAPA20200005391$aCoronavirus | |
| 650 | 4 | $0MAPA20080552022$aPandemias | |
| 650 | 4 | $0MAPA20080564872$aBiotecnología | |
| 650 | 4 | $0MAPA20080568641$aDigitalización | |
| 650 | 4 | $0MAPA20080557355$aBiomedicina | |
| 650 | 4 | $0MAPA20080557348$aBiomecánica | |
| 650 | 4 | $0MAPA20170006503$aTransformación digital | |
| 700 | 1 | $0MAPA20200011323$aEvers, Matthias | |
| 700 | 1 | $0MAPA20200011330$aZheng, Alice | |
| 710 | 2 | $0MAPA20080442569$aMcKinsey & Company |